Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

AGM Statement

31 Jul 2008 07:00

RNS Number : 2540A
Halma PLC
31 July 2008
 



HALMA p.l.c.

AGM Trading Update / Interim Management Statement

31 July 2008

Halma, the leading safety, health and sensor technology group, is holding its 114th AGM later today, at which Geoff Unwin, Chairman, will make the following statement. This announcement comprises the Group's Interim Management Statement relating to the period 30 March - 31 July 2008 and includes the first quarter's trading.

"Revenue and order intake for the first quarter of this financial year showed good growth over last year, which is in line with the Board's expectations.

"Underlying organic growth in all three Halma sectors (Infrastructure Sensors, Health & Analysis and Industrial Safety) was boosted further by a positive impact from currency movements of approximately 3%. In addition, Riester, the German medical instrumentation business acquired in December 2007, has performed well.

"We continue to see opportunities for sustained growth in our existing markets both organically and via acquisitions. This reflects our successful strategy of operating in diverse markets underpinned by resilient growth drivers such as the demand for energy and water resources, increasing demand for healthcare, rising expectations of health and safety and long term demographic trends.

"Our investment in building our business in developing markets continues. The new Halma 'hub' in Mumbai will be operational in October 2008 providing an important platform for more of our businesses to grow their commercial and technical presence in India. In Shanghai, the Halma manufacturing hub will be ready for occupancy in October 2008, enabling four more businesses to establish local product assembly and procurement in the Chinese market. Over the medium term, we expect the demand for our safety, health and environmentally related products to increase in both of these key territories.

"The Group's financial position continues to be strong and there have been no material events or transactions affecting the Group.

"As stated at the time of our year end results in June, the Board believes that Halma is well positioned to make further progress in the current year and beyond."

For further information, please contact:

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Tel: +44 (0)1494 721111

Hogarth Partnership Limited 

Rachel Hirst/Andrew Jaques

Tel: +44 (0)20 7357 9477

Notes:

1.

The half-yearly results for the period to 27 September 2008 are expected to be released on 27 November 2008.

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFKKKQPBKDPON
Date   Source Headline
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition
17th Jan 20227:00 amRNS2021 AGM – Voting Results Update Statement
30th Nov 20211:05 pmRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSAcquisition
18th Nov 20217:00 amRNSHalf Year Results
15th Nov 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.